Cibus (CBUS) Cash from Operations (2016 - 2025)
Cibus (CBUS) posted Cash from Operations of 13400000.0 for Q4 2025, down 13.86% sequentially from 11769000.0 in Q3 2025, and up 4.25% YoY from 12853529.81 in Q4 2024.
Cibus (CBUS) Cash from Operations (2016 - 2025) Analysis & Trends
Cibus has reported Cash from Operations for 10 years, with the latest figure at 13400000.0 in Q4 2025.
- Quarterly Cash from Operations rose 4.25% year-over-year to 13400000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 50600000.0 (up 12.82% YoY) and the FY2025 annual result came in at 50600000.0, up 12.82% from the prior year.
- Cash from Operations eased to 13400000.0 in Q4 2025 per CBUS's latest filing, from 11769000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 1832000.0 in Q2 2021 and troughed at 17048000.0 in Q2 2024.
- A 5-year average of 9651400.0 and a median of 11756500.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2021 and 2024: Cash from Operations surged 94.42% in 2021, then tumbled 467.58% in 2024.
- Over 5 years, Cash from Operations stood at 4157000.0 in 2021, then increased by 9.48% to 3763000.0 in 2022, then slumped by 352.22% to 17017000.0 in 2023, then rose by 17.76% to 13995000.0 in 2024, then climbed by 4.25% to 13400000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 13400000.0, 11769000.0, and 13631000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -13.40 Mn |
| Dec 31, 2025 | -13.40 Mn |
| Sep 30, 2025 | -11.77 Mn |
| Sep 30, 2025 | -11.77 Mn |
| Jun 30, 2025 | -13.63 Mn |
| Jun 30, 2025 | -13.63 Mn |
| Mar 31, 2025 | -11.80 Mn |
| Mar 31, 2025 | -11.80 Mn |
| Dec 31, 2024 | -14.00 Mn |
| Dec 31, 2024 | -14.00 Mn |
| Sep 30, 2024 | -13.52 Mn |
| Sep 30, 2024 | -13.52 Mn |
| Jun 30, 2024 | -17.05 Mn |
| Jun 30, 2024 | -17.05 Mn |
| Mar 31, 2024 | -13.48 Mn |
| Mar 31, 2024 | -13.48 Mn |
| Dec 31, 2023 | -17.02 Mn |
| Dec 31, 2023 | -17.02 Mn |
| Sep 30, 2023 | -15.07 Mn |
| Sep 30, 2023 | -15.07 Mn |